Unknown

Dataset Information

0

Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation.


ABSTRACT: Background:Adjuvant chemoradiation (CRT) is standard for head and neck squamous cell carcinoma (HNSCC) patients with positive margins or extranodal extension (ENE) following surgery. However, emerging evidence suggests the number of positive lymph nodes (LNs) is the dominant determinant of survival in non-oropharyngeal HNSCC and thus may better identify those benefiting from treatment intensification. Patients and methods:Patients from the National Cancer Database diagnosed with non-oropharyngeal HNSCC (oral cavity, larynx, hypopharynx) between 2004 and 2014 and undergoing surgical resection, neck dissection, and postoperative radiotherapy (RT) were included. Multivariable regression with first-order interaction terms was used to model the interaction between postoperative CRT and continuous number of positive LNs with respect to overall survival. Results:In total, 7144 patients met inclusion criteria. In multivariable analysis, increasing number of positive LNs was associated with both increasing mortality (P?

SUBMITTER: Zumsteg ZS 

PROVIDER: S-EPMC6336000 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation.

Zumsteg Z S ZS   Luu M M   Kim S S   Tighiouart M M   Mita A A   Scher K S KS   Lu D J DJ   Shiao S L SL   Mallen-St Clair J J   Ho A S AS  

Annals of oncology : official journal of the European Society for Medical Oncology 20190101 1


<h4>Background</h4>Adjuvant chemoradiation (CRT) is standard for head and neck squamous cell carcinoma (HNSCC) patients with positive margins or extranodal extension (ENE) following surgery. However, emerging evidence suggests the number of positive lymph nodes (LNs) is the dominant determinant of survival in non-oropharyngeal HNSCC and thus may better identify those benefiting from treatment intensification.<h4>Patients and methods</h4>Patients from the National Cancer Database diagnosed with n  ...[more]

Similar Datasets

| S-EPMC7352722 | biostudies-literature
| S-EPMC4415144 | biostudies-literature
| S-EPMC3443559 | biostudies-literature
| S-EPMC3816223 | biostudies-literature
| S-EPMC8356881 | biostudies-literature
| S-EPMC5270507 | biostudies-literature
2005-01-09 | E-UMCU-11 | biostudies-arrayexpress
| S-EPMC6420850 | biostudies-literature
| S-EPMC4714679 | biostudies-literature